Cancers, Free Full-Text
Por um escritor misterioso
Descrição
Neuroblastoma is the most common extracranial solid pediatric tumor, with around 15% childhood cancer-related mortality. High-risk neuroblastomas exhibit a range of genetic, morphological, and clinical heterogeneities, which add complexity to diagnosis and treatment with existing modalities. Identification of novel therapies is a high priority in high-risk neuroblastoma, and the combination of genetic analysis with increased mechanistic understanding—including identification of key signaling and developmental events—provides optimism for the future. This focused review highlights several recent findings concerning chromosomes 1p, 2p, and 11q, which link genetic aberrations with aberrant molecular signaling output. These novel molecular insights contribute important knowledge towards more effective treatment strategies for neuroblastoma.
Hallmarks of Cancer: The Next Generation: Cell
Science and health for all children with cancer
Cancer Awareness Month Calendar & Ribbon Color
Cancer Free Posters for Sale
Pancreatic Cancer Action Network – Research, Patient Support, Resources
Frontiers Hypoxia-Modified Cancer Cell Metabolism
Working with Filters - My NCBI Help - NCBI Bookshelf
Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes, Breast Cancer Research
Stand Up To Cancer - Cancer Research Charity
Cancer Ribbon Colors: The Ultimate Guide
Join a FREE Breast Cancer Survivorship Program
Predicting peritoneal recurrence and disease-free survival from CT images in gastric cancer with multitask deep learning: a retrospective study - The Lancet Digital Health
Information and Resources about for Cancer: Breast, Colon, Lung, Prostate, Skin
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
Home - Free ME from Lung Cancer
